Full Name
Simon McKenzie Cool
Cool, S.
Cool, S.M.
Main Affiliation


Results 1-20 of 46 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
12007A novel use of TAT-EGFP to validate techniques to alter osteosarcoma cell surface glycosaminoglycan expressionKumarasuriyar, A.; Dombrowski, C.; Rider, D.A.; Nurcombe, V. ; Cool, S.M. 
22008A simple and reliable electroporation method for human bone marrow mesenchymal stem cellsHelledie, T.; Nurcombe, V. ; Cool, S.M. 
32019Autologous bone marrow clot as an alternative to autograft for bone defect healingLim, Z.X.H.; Rai, B.; Tan, T.C.; Ramruttun, A.K. ; Hui, J.H.; Nurcombe, V.; Teoh, S.H.; Cool, S.M. 
42006Bone-specific heparan sulfates induce osteoblast growth arrest and downregulation of retinoblastoma proteinManton, K.J.; Sadasivam, M.; Cool, S.M. ; Nurcombe, V. 
52013Complexation and Sequestration of BMP-2 from an ECM Mimetic Hyaluronan Gel for Improved Bone FormationKisiel M.; Klar A.S.; Ventura M.; Buijs J.; Mafina M.-K.; Cool S.M. ; Hilborn J.
62007Concepts of scaffold-based tissue engineering - The rationale to use solid free-form fabrication techniquesHutmacher, D.W.; Cool, S. 
7Mar-2006Controlled release of heparin from poly(ε-caprolactone) electrospun fibersLuong-Van, E.; Grøndahl, L.; Chua, K.N.; Leong, K.W.; Nurcombe, V.; Cool, S.M. 
82006Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesisJackson, R.A.; Nurcombe, V. ; Cool, S.M. 
92009De-sulfation of MG-63 cell glycosaminoglycans delays in vitro osteogenesis, up-regulates cholesterol synthesis and disrupts cell cycle and the actin cytoskeletonKumarasuriyar, A.; Lee, I.; Nurcombe, V. ; Cool, S.M. 
102007Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathwaysManton, K.J.; Leong, D.F.M.; Cool, S.M. ; Nurcombe, V. 
112020Enhancing the Efficacy of Stem Cell Therapy with GlycosaminoglycansLing, L.; Ren, X. ; Cao, X. ; Hassan, A.B.M. ; Mah, S.; Sathiyanathan, P.; Smith, R.A.A.; Tan, C.L.L.; Eio, M.; Samsonraj, R.M.; van Wijnen, A.J.; Raghunath, M. ; Nurcombe, V.; Hui, J.H.; Cool, S.M. 
122015Establishing criteria for human mesenchymal stem cell potencySamsonraj, R.M; Rai, B; Sathiyanathan, P; Puan, K.J; Rötzschke, O; Hui, J.H ; Raghunath, M; Stanton, L.W ; Nurcombe, V; Cool, S.M 
132007Glycosaminoglycan and growth factor mediated murine calvarial cell proliferationManton, K.J.; Haupt, L.M.; Vengadasalam, K.; Nurcombe, V. ; Cool, S.M. ; Manton, K.J.
142009Glycosaminoglycan composition changes with MG-63 osteosarcoma osteogenesis in vitro and induces human mesenchymal stem cell aggregationKumarasuriyar, A.; Murali, S.; Nurcombe, V. ; Cool, S.M. 
152020Heparan Sulfate Proteoglycans: Key Mediators of Stem Cell FunctionRavikumar, M.; Smith, R.A.A.; Nurcombe, V.; Cool, S.M. 
162007Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2Jackson, R.A.; Murali, S.; Nurcombe, V. ; Cool, S.M. ; Van, Wijnen A.J.; Stein, G.S.
172006Heparan sulfate regulation of progenitor cell fateCool, S.M. ; Nurcombe, V. 
182015Human mesenchymal stem cells retain multilineage differentiation capacity including neural marker expression after extended in vitro expansionOkolicsanyi R.K.; Camilleri E.T.; Oikari L.E.; Yu C.; Cool S.M. ; Van Wijnen A.J.; Griffiths L.R.; Haupt L.M.
192016Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant productionCamilleri, E.T; Gustafson, M.P; Dudakovic, A; Riester, S.M; Garces, C.G; Paradise, C.R; Takai, H; Karperien, M; Cool, S ; Sampen, H.-J.I; Larson, A.N; Qu, W; Smith, J; Dietz, A.B; Van Wijnen, A.J
202018Improved recovery from limb ischaemia by delivery of an affinity-isolated heparan sulphatePoon, S; Lu, X; Smith, R.A.A; Ho, P ; Bhakoo, K ; Nurcombe, V; Cool, S.M